Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2017.05.22
关于筹划发行股份购买资产的停牌进展公告
2017.05.22
关于选举职工代表监事的公告
2017.05.15
关于筹划发行股份购买资产停牌公告
2017.05.08
重大事项进展及继续停牌公告
2017.04.28
关于召开2016年度股东大会的通知公告
2017.04.28
第三届监事会第二十四次会议决议公告
2017.04.28
关于公司会计政策变更的公告
2017.04.28
关于新增募集资金专项存储账户并转款的公告
2017.04.28
关于签署关联交易协议的公告
2017.04.28
2016年度内部控制自我评价报告
第一页
上一页
77
78
79
80
81
下一页
最后一页
